New Hybrid Compounds Incorporating Natural Products as Multifunctional Agents against Alzheimer's Disease

L Ciccone, C Camodeca, N Tonali, L Barlettani… - Pharmaceutics, 2023 - mdpi.com
A series of new hybrid derivatives 1a–c, 2a–c, 3a–c, 4a–c, 5a–c, inspired by nature, were
synthesized and studied as multifunctional agents for the treatment of Alzheimer's disease …

Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for …

J Wang, P Cai, XL Yang, F Li, JJ Wu, LY Kong… - European journal of …, 2017 - Elsevier
By using fragments endowed with interesting and complementary properties for the
treatment of Alzheimer's disease (AD), a novel series of cinnamamide-dibenzylamine …

Design, synthesis and biological evaluation of novel carboline-cinnamic acid hybrids as multifunctional agents for treatment of Alzheimer's disease

Q Liao, Q Li, Y Zhao, P Jiang, Y Yan, H Sun, W Liu… - Bioorganic …, 2020 - Elsevier
Alzheimer's disease (AD) is a complex neurodegenerative disease with multiple
pathological features. Multifunctional compounds able to simultaneously interact with …

Natural compounds and their derivatives as multifunctional agents for the treatment of Alzheimer disease

R Tundis, MR Loizzo, SM Nabavi, IE Orhan… - … and Development of …, 2018 - Elsevier
Alzheimer disease (AD) is a complex and progressive neurodegenerative disease. AD is
one of the greatest challenges to modern medicine because multiple pathogenetic factors …

Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents

W Luo, YB Su, C Hong, RG Tian, LP Su… - Bioorganic & medicinal …, 2013 - Elsevier
A series of 4-dimethylamine flavonoid derivatives 5a–5r were designed, synthesized and
evaluated as potential multi-functional anti-Alzheimer agents. The results showed that most …

Natural scaffolds with multi-target activity for the potential treatment of Alzheimer's disease

L Piemontese, G Vitucci, M Catto, A Laghezza… - Molecules, 2018 - mdpi.com
A few symptomatic drugs are currently available for Alzheimer's Disease (AD) therapy, but
these molecules are only able to temporary improve the cognitive capacity of the patients if …

Current progresses of novel natural products and their derivatives/analogs as anti-Alzheimer candidates: an update

L Fang, S Gou, X Fang, L Cheng… - Mini reviews in …, 2013 - ingentaconnect.com
Alzheimer's disease (AD) is one of the most threatening diseases affecting the aged with
high incidence. Though AD has been defined for more than 100 years, it is still incurable …

Non-conventional compounds with potential therapeutic effects against Alzheimer's disease

AA de Castro, FV Soares, AF Pereira… - Expert Review of …, 2019 - Taylor & Francis
Introduction: Alzheimer's disease (AD) is the most common cause of dementia. Clinical
progress in this pathogenesis field has drawn the attention of researchers, stimulating the …

Nature-based molecules combined with rivastigmine: A symbiotic approach for the synthesis of new agents against Alzheimer's disease

G Nesi, Q Chen, S Sestito, M Digiacomo, X Yang… - European Journal of …, 2017 - Elsevier
Starting from nature as original source, new potential agents with pleiotropic activities have
been synthesized and evaluated as neuroprotective agents. In this work, novel nature-based …

Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease

N Guzior, A Wieckowska, D Panek… - Current medicinal …, 2015 - ingentaconnect.com
Alzheimer's disease (AD) is a complex and progressive neurodegenerative disorder. The
available therapy is limited to the symptomatic treatment and its efficacy remains …